(Q54558412)

31 May 2018

title

Penetration characteristics of cefamandole into the right atrial appendage and pericardial fluid in patients undergoing open-heart surgery. (English)

1 reference

31 May 2018

author name string

N H Olson

series ordinal

1

1 reference

31 May 2018

C H Nightingale

series ordinal

2

1 reference

31 May 2018

R Quintiliani

series ordinal

3

1 reference

31 May 2018

language of work or name

English

0 references

publication date

1 February 1980

1 reference

31 May 2018

The Annals of Thoracic Surgery

published in

1 reference

31 May 2018

volume

29

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

104-108

1 reference

31 May 2018

Comparison of Cephalothin and Cefamandole Prophylaxis During Insertion of Prosthetic Heart Valves

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Clinical Pharmacology of Cefamandole as Compared with Cephalothin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Infection after cardiovascular surgery. Clinical study including examination of antimicrobial prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Binding rate of antibacterials to serum proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Cefamandole: in vitro and clinical pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Observations in man on some pharmacologic features of cefamandole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Influence of binding on the pharmacologic activity of antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Pharmacokinetics of cefamandole in patients with normal and impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Antibacterial Activity of Cefamandole III Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Pharmacological Studies with Cefamandole in Human Volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

Penetration of Cephapirin and Cephalothin into the Right Atrial Appendage and Pericardial Fluid of Patients Undergoing Open-Heart Surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

In Vitro Activity and Pharmacokinetics in Patients of Cefamandole, a New Cephalosporin Antibiotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2810%2961644-X

10.1016/S0003-4975(10)61644-X

7 January 2021

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018